<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37163449</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>V-Set Immunoglobulin Domain-Containing Protein 4 as a Novel Serum Biomarker of Lupus Nephritis and Renal Pathology Activity.</ArticleTitle><Pagination><StartPage>1573</StartPage><EndPage>1585</EndPage><MedlinePgn>1573-1585</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.42545</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To discover novel serum biomarkers that have diagnostic or predictive value in lupus nephritis (LN).</AbstractText><AbstractText Label="METHODS">Using a quantitative protein microarray, we screened for high-abundant proteome expression in the serum of patients with LN compared to healthy controls. Top candidates from this screening were validated using a larger cohort of patients with LN compared to a disease control cohort (subjects with other chronic kidney diseases) and a healthy control cohort. Promising markers were then selected using a machine-learning model and further validated with a larger patient cohort. The corresponding autoantibodies and immune complexes containing these proteins were also examined.</AbstractText><AbstractText Label="RESULTS">In total, 13 proteins were found to be significantly elevated in LN patient serum in the screening, among which 8 proteins were validated by enzyme-linked immunosorbent assay using 81 serum samples from LN patients and control subjects. Three serum markers with LN diagnostic potential were identified using feature importance analysis and further validated using 155 serum samples from LN patients and control subjects. V-set immunoglobulin domain-containing protein 4 (VSIG4) appeared to be the most promising marker in distinguishing LN from healthy controls, with an area under the curve of 0.93. VSIG4 could also discriminate active LN from inactive LN. Furthermore, serum VSIG4 levels were positively correlated with all of the following clinical parameters: the Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) score (Spearman's rank correlation r<sub>s</sub> =&#x2009;0.42, P &lt;&#x2009;0.001), the renal domain score of the SLEDAI (r<sub>s</sub> =&#x2009;0.46, P &lt;&#x2009;0.001), the urinary protein-to-creatinine ratio (r<sub>s</sub> =&#x2009;0.56, P &lt;&#x2009;0.001), and the serum creatinine level (r<sub>s</sub> =&#x2009;0.41, P &lt;&#x2009;0.001). Importantly, we found that serum VSIG4 levels tracked with LN disease activity longitudinally, and that serum VSIG4 levels reflected the renal pathology activity index (AI), particularly the AI components of crescent formation and hyaline deposits.</AbstractText><AbstractText Label="CONCLUSION">VSIG4 may be a promising novel serum biomarker and therapeutic target in patients with LN.</AbstractText><CopyrightInformation>&#xa9; 2023 American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Chenling</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teymur</LastName><ForeName>Aygun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Bowen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazir</LastName><ForeName>Fariz</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Texas Southwestern Medical Center, Dallas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saxena</LastName><ForeName>Ramesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Nephrology, University of Texas Southwestern Medical Center, Dallas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>Nancy J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohan</LastName><ForeName>Chandra</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Tianfu</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4406-1449</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Engineering, University of Houston, Houston, Texas.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG062987</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C414427">VSIG4 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000070557" MajorTopicYN="N">Immunoglobulin Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051436" MajorTopicYN="Y">Renal Insufficiency, Chronic</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>COMPETING INTERESTS</b> None</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>10</Day><Hour>13</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37163449</ArticleId><ArticleId IdType="mid">NIHMS1897116</ArticleId><ArticleId IdType="pmc">PMC10524163</ArticleId><ArticleId IdType="doi">10.1002/art.42545</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schwartz N, Goilav B, Putterman C. The pathogenesis, diagnosis and treatment of lupus nephritis. Current opinion in rheumatology. 2014;26(5):502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4221732</ArticleId><ArticleId IdType="pubmed">25014039</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nat Rev Dis Primers. 2020;6(1):7.</Citation><ArticleIdList><ArticleId IdType="pubmed">31974366</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon C, Jayne D, Pusey C, Adu D, Amoura Z, Aringer M, et al. European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus. 2009;18(3):257&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">19213865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zickert A, Sundelin B, Svenungsson E, Gunnarsson I. Role of early repeated renal biopsies in lupus nephritis. Lupus science &amp; medicine. 2014;1(1):e000018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4213828</ArticleId><ArticleId IdType="pubmed">25379188</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra R, Gupta R. Biomarkers in lupus nephritis. International Journal of Rheumatic Diseases. 2015;18(2):219&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">25884459</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Thomas J, Blanco I, Putterman C. Urinary biomarkers in lupus nephritis. Clinical reviews in allergy &amp; immunology. 2011;40(3):138&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2917506</ArticleId><ArticleId IdType="pubmed">20127204</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan G, Baby B, Zhou Y, Wu T. Emerging Molecular Markers Towards Potential Diagnostic Panels for Lupus. Frontiers in Immunology. 2021;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8792845</ArticleId><ArticleId IdType="pubmed">35095896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Mohan C. Proteomic toolbox for autoimmunity research. Autoimmunity Reviews. 2009;8(7):595&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19393208</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Z, Dodig-Crnkovic T, Schwenk JM, Tao SC. Current applications of antibody microarrays. Clin Proteomics. 2018;15:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5830343</ArticleId><ArticleId IdType="pubmed">29507545</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlsson A, Wuttge DM, Ingvarsson J, Bengtsson AA, Sturfelt G, Borrebaeck CA, et al. Serum protein profiling of systemic lupus erythematosus and systemic sclerosis using recombinant antibody microarrays. Molecular &amp; cellular proteomics. 2011;10(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3098590</ArticleId><ArticleId IdType="pubmed">21350050</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Ding H, Han J, Arriens C, Wei C, Han W, et al. Antibody-array-based proteomic screening of serum markers in systemic lupus erythematosus: a discovery study. Journal of proteome research. 2016;15(7):2102&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5193538</ArticleId><ArticleId IdType="pubmed">27211902</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Wu T. Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery. Expert Opinion on Drug Discovery. 2018;13(8):765&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">29863906</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, et al. InterPro: the integrative protein signature database. Nucleic Acids Research. 2009;37:D211&#x2013;D5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2686546</ArticleId><ArticleId IdType="pubmed">18940856</ArticleId></ArticleIdList></Reference><Reference><Citation>Dittrich MT, Klau GW, Rosenwald A, Dandekar T, Muller T. Identifying functional modules in protein-protein interaction networks: an integrated exact approach. Bioinformatics. 2008;24(13):I223&#x2013;I31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2718639</ArticleId><ArticleId IdType="pubmed">18586718</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng W, Chen W, Zhang Z, Huang S, Kong W, Sun Y, et al. Mesenchymal stem cells promote CD206 expression and phagocytic activity of macrophages through IL-6 in systemic lupus erythematosus. Clin Immunol. 2015;161(2):209&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">26209923</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajic-Veljic M, Lekic B, Nikolic M, Lalosevic J, Stojimirovic B, Bonaci-Nikolic B. Level and avidity of antineutrophil cytoplasmic antibodies specific to lactoferrin are useful biomarkers in systemic lupus erythematosus. Clin Rheumatol. 2022;41(3):709&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">34618258</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, Liu J, Zhou J, Sun L, Li C, Li X, et al. Serum proteomics study reveals candidate biomarkers for systemic lupus erythematosus. Int J Clin Exp Pathol. 2017;10(10):10681&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6965801</ArticleId><ArticleId IdType="pubmed">31966412</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolidis SA, Stifano G, Tabib T, Rice LM, Morse CM, Kahaleh B, et al. Single Cell RNA Sequencing Identifies HSPG2 and APLNR as Markers of Endothelial Cell Injury in Systemic Sclerosis Skin. Front Immunol. 2018;9:2191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174292</ArticleId><ArticleId IdType="pubmed">30327649</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi Q, Dong F, Lin L, Liu Q, Chen S, Gao F, et al. PRSS1 mutations and the proteinase/antiproteinase imbalance in the pathogenesis of pancreatic cancer. Tumour Biol. 2016;37(5):5805&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">26546433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, Li Y, Wang C, Zhuang Z, Liu Q, Chen J, et al. Identification of a novel frame-shift mutation in PRSS1 gene in Han patients with autoimmune pancreatitis. Current Molecular Medicine. 2014;14(3):340&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24236450</ArticleId></ArticleIdList></Reference><Reference><Citation>Koffler D, Agnello V, Kunkel HG. Polynucleotide immune complexes in serum and glomeruli of patients with systemic lupus erythematosus. The American Journal of Pathology. 1974;74(1):109.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1910734</ArticleId><ArticleId IdType="pubmed">4809310</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Fang M, Tan G, Zhang S, Yang B, Li Y, et al. Discovery of Novel Circulating Immune Complexes in Lupus Nephritis Using Immunoproteomics. Front Immunol. 2022;13:850015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8996714</ArticleId><ArticleId IdType="pubmed">35419005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Y, Wu T, Zhang T, Han J, Habazi D, Saxena R, et al. Elevated oxidized lipids, anti-lipid autoantibodies and oxidized lipid immune complexes in active SLE. Clin Immunol. 2019;205:43&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31075396</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders H-J, Saxena R, Zhao M-h, Parodis I, Salmon JE, Mohan C. Lupus nephritis. Nature reviews Disease primers. 2020;6(1):1&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">31974366</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. Joint European League Against Rheumatism and European Renal Association&#x2013;European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Annals of the rheumatic diseases. 2012;71(11):1771&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3465859</ArticleId><ArticleId IdType="pubmed">22851469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull KL, Adenwalla SF, Topham P, Graham-Brown MP. Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist. Clinical Medicine. 2022;22(1):34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8813013</ArticleId><ArticleId IdType="pubmed">34921054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Du Y, Han J, Singh S, Xie C, Guo Y, et al. Urinary angiostatin-a novel putative marker of renal pathology chronicity in lupus nephritis. Molecular &amp; Cellular Proteomics. 2013;12(5):1170&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3650329</ArticleId><ArticleId IdType="pubmed">23345539</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Wu T, Xie C, Vanarsa K, Han J, Mahajan T, et al. Urine VCAM-1 as a marker of renal pathology activity index in lupus nephritis. Arthritis research &amp; therapy. 2012;14(4):1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580557</ArticleId><ArticleId IdType="pubmed">22788914</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinchliffe TE, Lin ZT, Wu T. Protein arrays for biomarker discovery in lupus. PROTEOMICS&#x2013;Clinical Applications. 2016;10(6):625&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">26684273</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Yu Y-F, Liu C-H, Wang C-M. Significance of M2 macrophages in glomerulonephritis with crescents. Pathology-Research and Practice. 2017;213(9):1215&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28554749</ArticleId></ArticleIdList></Reference><Reference><Citation>Jariwala MP, Laxer RM. Primary vasculitis in childhood: GPA and MPA in childhood. Frontiers in Pediatrics. 2018;6:226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6107029</ArticleId><ArticleId IdType="pubmed">30167431</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, Li Y-M, Hong G-L, Xu Z-F, Liu Q-C, He Q-L, et al. PRSS1_p. Leu81Met mutation results in autoimmune pancreatitis. World Journal of Gastroenterology: WJG. 2013;19(21):3332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3671086</ArticleId><ArticleId IdType="pubmed">23745036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong L, Liu J, Zhou J, Sun L, Li C, Li X, et al. Serum proteomics study reveals candidate biomarkers for systemic lupus erythematosus. International journal of clinical and experimental pathology. 2017;10(10):10681.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6965801</ArticleId><ArticleId IdType="pubmed">31966412</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoskar AA, Shapiro JP, Bott CN, Song H, Nadasdy GM, Brodsky SV, et al. Characterization of glomerular diseases using proteomic analysis of laser capture microdissected glomeruli. Modern Pathology. 2012;25(5):709&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3432020</ArticleId><ArticleId IdType="pubmed">22282304</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolidis SA, Stifano G, Tabib T, Rice LM, Morse CM, Kahaleh B, et al. Single cell RNA sequencing identifies HSPG2 and APLNR as markers of endothelial cell injury in systemic sclerosis skin. Frontiers in immunology. 2018;9:2191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174292</ArticleId><ArticleId IdType="pubmed">30327649</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Xu L, Wang P, Liang X, Qi J, Liu P, et al. Increased expression of human T-cell immunoglobulin-and mucin-domain-containing molecule-4 in peripheral blood mononuclear cells from patients with system lupus erythematosus. Cellular &amp; Molecular Immunology. 2010;7(2):152&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001890</ArticleId><ArticleId IdType="pubmed">20140011</ArticleId></ArticleIdList></Reference><Reference><Citation>Busch R, Hadjinicolaou AV, Hall FC. Local activation and systemic dysregulation of T lymphocytes in Sjogren&#x2019;s syndrome. Current pharmaceutical biotechnology. 2012;13(10):2009&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">22208658</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagler DK, Zhang R, Tam W, Sulea T, Purisima EO, Menard R. Human cathepsin X: A cysteine protease with unique carboxypeptidase activity. Biochemistry. 1999;38(39):12648&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">10504234</ArticleId></ArticleIdList></Reference><Reference><Citation>Allan ERO, Campden RI, Ewanchuk BW, Tailor P, Balce DR, McKenna NT, et al. A role for cathepsin Z in neuroinflammation provides mechanistic support for an epigenetic risk factor in multiple sclerosis. J Neuroinflammation. 2017;14(1):103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5424360</ArticleId><ArticleId IdType="pubmed">28486971</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt L, Schmitz N, Kurrer MO, Bauer M, Hinton HI, Behnke S, et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. J Clin Invest. 2006;116(10):2817&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1578631</ArticleId><ArticleId IdType="pubmed">17016562</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Diao B, Guo S, Huang X, Yang C, Feng Z, et al. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nat Commun. 2017;8(1):1322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5673889</ArticleId><ArticleId IdType="pubmed">29109438</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Sun Z, Li L, Liu J, He J, Song D, et al. Induction of T cells suppression by dendritic cells transfected with VSIG4 recombinant adenovirus. Immunol Lett. 2010;128(1):46&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">19914289</ArticleId></ArticleIdList></Reference><Reference><Citation>Anania VG, Yu K, Pingitore F, Li Q, Rose CM, Liu P, et al. Discovery and qualification of candidate urinary biomarkers of disease activity in lupus nephritis. Journal of proteome research. 2018;18(3):1264&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">30525646</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Feng Z, Jiang Y, Li J, Xiang Q, Guo S, et al. VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1beta in macrophages. Sci Adv. 2019;5(1):eaau7426.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326752</ArticleId><ArticleId IdType="pubmed">30662948</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Yao W, Sun L, Li G, Liu H, Ding P, et al. The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice. BMC Nephrol. 2019;20(1):424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6873683</ArticleId><ArticleId IdType="pubmed">31752725</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607&#x2013;D13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8 Suppl 4:S11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC403769</ArticleId><ArticleId IdType="pubmed">14597658</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: Machine Learning in Python. J Mach Learn Res. 2011;12:2825&#x2013;30.</Citation></Reference><Reference><Citation>Hunter JD. Matplotlib: A 2D graphics environment. Comput Sci Eng. 2007;9(3):90&#x2013;5.</Citation></Reference><Reference><Citation>Hao Y, Hao S, Andersen-Nissen E, Mauck WM 3rd, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184(13):3573&#x2013;87 e29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8238499</ArticleId><ArticleId IdType="pubmed">34062119</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe AR, Yue W. Semi-quantitative Determination of Protein Expression using Immunohistochemistry Staining and Analysis: An Integrated Protocol. Bio Protoc. 2019;9(24).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6924920</ArticleId><ArticleId IdType="pubmed">31867411</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T, Du Y, Han J, Singh S, Xie C, Guo Y, et al. Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis. Mol Cell Proteomics. 2013;12(5):1170&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3650329</ArticleId><ArticleId IdType="pubmed">23345539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wickham H, Chang W, Henry L, Pedersen TL, Takahashi K, Wilke C, et al. ggplot2: Create elegant data visualisations using the grammar of graphics. R package version. 2016;2(1).</Citation></Reference><Reference><Citation>Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Taiyun WV, Simko. R package &#x2018;corrplot&#x2019;: Visualization of a Correlation Matrix. 2021.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>